General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-08-08 | 2024-06 | -1.27 | N/A | N/A | N/A |
2024-05-09 | 2024-03 | -1.28 | -1.5 | -0.22 | -17.19% |
2024-03-18 | 2023-12 | -2.8 | -2.3 | 0.5 | 17.86% |
2023-11-09 | 2023-09 | -3 | -3.3 | -0.3 | -10.00% |
2023-08-10 | 2023-06 | -3.2 | -3.1 | 0.1 | 3.13% |
2023-05-11 | 2023-03 | -3 | -2.9 | 0.1 | 3.33% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-09-04 | Truist Securities | Upgrade | Buy | Buy |
2023-08-10 | Chardan Capital | Upgrade | Neutral | Buy |
2023-03-06 | Ladenburg Thalmann | Upgrade | Buy | |
2022-11-10 | Chardan Capital | Upgrade | Neutral | |
2022-11-10 | RBC Capital | Upgrade | Sector Perform | |
2022-08-11 | Chardan Capital | Upgrade | Neutral |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2022-09-18 | BECKMAN RICHARD L. | Officer | 39.06K | Sale |
2022-05-16 | D'SOUZA RUPERT | Chief Financial Officer | 20.85K | Purchase |
2023-03-14 | FISCHER LAURENT D M.D. | Chief Executive Officer | 692.14K | Sale |
2024-02-06 | LUPHER MARK L. JR., PH.D. | Director | 0.00 | Purchase |
2023-03-14 | RILEY BRIGIT | Officer | 117.44K | Sale |
2023-06-06 | RUBINSTEIN LINDA M. | Chief Financial Officer | 100.00K | Purchase |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Commodore Capital Lp | 10.00M | 15.90M | 9.90% |
2023-06-29 | FMR, LLC | 7.76M | 12.34M | 7.68% |
2023-06-29 | Morgan Stanley | 6.97M | 11.08M | 6.90% |
2023-06-29 | Bank of America Corporation | 5.59M | 8.89M | 5.54% |
2023-06-29 | Bml Capital Management, Llc | 5.16M | 8.20M | 5.11% |
2023-06-29 | Versant Venture Management, LLC | 5.07M | 8.06M | 5.02% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-08-30 | Fidelity Select Portfolios - Biotechnology | 6.90M | 12.01M | 6.83% |
2023-06-29 | Vanguard Total Stock Market Index Fund | 2.66M | 4.23M | 2.64% |
2023-06-29 | Vanguard Extended Market Index Fund | 1.23M | 1.95M | 1.21% |
2023-05-30 | Fidelity Extended Market Index Fund | 432.11K | 531.50K | 0.43% |
2023-06-29 | Fidelity Small Cap Enhanced Index Fund | 173.97K | 276.61K | 0.17% |
2023-05-30 | Fidelity Total Market Index Fund | 128.64K | 158.23K | 0.13% |
Split | Date |
---|---|
1 : 10 | 2024-03-21 |
Always buying more.
Nice rebound!
I long for the day when people lose everything because they “invested” in an imaginary asset and then jump off skyscrapers...
Yeah. Doge coin and fairy dust.
The only thing that beats the shorts is large block buys. Until then watch it fall
I will continue add to my position every time it drops. I do not believe the trial was the cause of the patient going blind.
It will be a couple weeks before they complete further analysis of all the patients involved and come to a conclusion.
I just keep buying more. This we rebound hard once they announce the trial was not the cause of the blindness. The patient was going blind already, hence being in the trial...
Thousands of shorts coming in
Basically on a triple bottom right now at $3.78
Shorts are already at work
When RA Capital and the others down to Blackrock speak, I might listen then. Otherwise Sonic sounds like a crybaby that wants attention...
Sonic is the least invested in this. Why do you give them so much authority to dictate the future?
Or not...
Bids enough to hold up I think
Down trend has broken at $3.94. Time to buy it up
Wow. Battle for $4.00 again?